In the present study, we intended to investigate the influence of different clinical prognostic factors, particularly baseline hemoglobin (Hb) levels, on treatment outcomes within a cohort of anal cancer patients submitted to combined RT and CT. The gene discussed is GSTM1; the disease is anal carcinoma.